Jiuzhou Pharmaceutical announced that Jiuzhou Biomedical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for tandospirone citrate tablets approved and issued by the State Drug Administration. The specifications are 5 mg and 10 mg. The approval numbers are Sinopharm Standard H20265796 and Sinopharm Standard H20265797, which is valid until September 1, 2031.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.